Navigation Links
CardioGenics Holdings Inc. Featured in Medical Device Daily

MISSISSAUGA, Ontario, Nov. 13 /PRNewswire-FirstCall/ -- CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH), a developer of technology and products targeting the immunoassay segment of the IVD testing market, was featured in Medical Device Daily's November 12, 2009 edition.

The article by Amanda Petersen, titled "CardioGenics aims to offer faster heart attack diagnosis," shares insights from CardioGenics CEO Yahia Gawad, MD regarding the company's point-of-care (POC) cardiac diagnostic technology. This technology includes the QL Care® Analyzer, designed to provide a more rapid diagnosis of heart attacks, to meet the guidelines established by the American Heart Association and the American College of Cardiology. It also includes the company's highly reflective paramagnetic beads, intended as a more light-sensitive alternative to beads currently used in 90% of medical lab analyzers.

The Medical Device Daily piece explains, "Speed of diagnosis is important when physicians are dealing with possible heart attack patients because they need to decide quickly how they are going to treat the patient, if they are going to be aggressive or use a more conservative therapy." In the article, Dr. Gawad notes, "For every hour you delay treating the patient it costs three lives, so the time is extremely important." Equally crucial, the article reports Gawad as saying, is the need to base that treatment decision on a sound diagnosis. The use of this POC test could reduce healthcare costs and offer faster diagnosis, Gawad states in the article.

The article goes on to describe the single-use cartridge QL Care® Analyzer, which CardioGenics states as offering a "quantum leap" in existing POC immunoassay technology: "In just six steps, the QL Care® Analyzer provides printed medical lab quality results in less than fifteen minutes." Gawad is reported in the article as noting that the company's initial target for the device is emergency rooms, chest pain clinics, and cardiac care units, but could be used in ambulances as well. CardioGenics is also reported as anticipating that the device cartridge can be ultimately adapted to run any number of immunoassay tests.

The article goes on to describe CardioGenics' other lead product, silver-coated magnetic beads that are more reflective and capable of delivering sensitivity five-to-ten times higher than competitive products in the chemiluminescence testing space.

The Medical Device Daily article is available online at

About CardioGenics Holdings Inc.

CardioGenics is dedicated to developing more sensitive diagnostic test products for the IVD market. CardioGenics has started several developmental processes aimed to achieve its objective "to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies." CardioGenics' operating philosophy is that "better diagnosis enhances the healthcare professionals' ability to provide better patient management which saves lives and reduces healthcare costs." Fulfilling unmet clinical testing needs is the driving force behind CardioGenics' innovations. Its current products include the QL Care Analyzer ("QLCA"), a state-of-the-art proprietary point of care ("POC") immunoanalyzer; a series of immunoassay tests to detect cardiac markers; and a proprietary method for improving the light collection from paramagnetic beads ("Beads"). You can learn more about CardioGenics at (

SOURCE CardioGenics Holdings Inc.

SOURCE CardioGenics Holdings Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CardioGenics Holdings Inc. Announces Letter to Shareholders
2. CardioGenics Holdings Inc. Provides Update on FINRA Submission Regarding Name Change
3. Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes
4. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
5. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
6. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Fourth Quarter Earnings and 2010 Financial Guidance Webcast
7. Select Medical Holdings Corporation Announces Exercise of Underwriters Option to Purchase Additional Shares
8. Lincare Holdings Inc. Extends Terms of Employment Agreements with Executive Officers
9. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2009 Results
10. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
11. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
Post Your Comments:
(Date:11/30/2015)... 2015 North America was ... grow at a CAGR of 7.6% from 2015 to 2020. ... 135.6 million in 2014, and is expected to grow at a ... to the new Market Research Report "North America Cardiac Output Monitoring ... (Hospitals, ambulatory care, others) - Analysis And Forecast To 2020", the ...
(Date:11/30/2015)... --> --> ... by Product (Soft Tissue, All Tissue, Dental Welding Lasers), Application ... Geography - Global Forecast to 2020", published by MarketsandMarkets, is ... CAGR of 5.2% during the forecast period from 2015 to ... 62 Figures spread through 167 P ages and in-depth ...
(Date:11/30/2015)... MOUNTLAKE TERRACE, Wash. and ST. ... Cross and Express Scripts (NASDAQ: ESRX ) today ... benefit agreement. The partnership, which began in 1999, will ... --> --> After evaluating pharmacy ... process, Premera concluded that Express Scripts continues to offer ...
Breaking Medicine Technology:
(Date:11/30/2015)... , ... December 01, 2015 , ... ... Dale Jones as a 2015-2016 inductee into its VIP Woman of the ... NAPW is the nation’s leading networking organization exclusively for professional women, boasting 850,000 ...
(Date:11/30/2015)... ... December 01, 2015 , ... Live Very Well is ... insurance plans on . The multi-carrier insurance exchange platform offers individual ... allowing consumers to compare, quote and match plans to meet their needs. ...
(Date:11/30/2015)... ... 30, 2015 , ... Until now, the St. Louis Fetal Care Institute ... of Myelomeningocele Study) trial. One of these exclusion criteria was a BMI above 34.9. ... to 24.9 is considered normal, 25 - 29.9 is overweight and above 30 is ...
(Date:11/30/2015)... , ... November 30, 2015 , ... Stress, anxiety, illness, ... a parent worry about possible tumors? , Heather Spader, MD, a new pediatric neurosurgeon ... are common, some signs might point to tumors. , “Bad headaches that ...
(Date:11/30/2015)... ... November 30, 2015 , ... Thermi™, a world leader in ... its ThermiRFR temperature controlled radiofrequency platform has received CE marking and may now ... uses temperature as a clinical endpoint. The technology has been available in ...
Breaking Medicine News(10 mins):